Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00629_DB00730_nanopub.RAJwbxZpNH_-7rJoxZ4uI67W5tZq_uiiAtdFl6rJhYAkk#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00629_DB00730 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00629_DB00730 label "DDI between Guanabenz and Thiabendazole - The strong CYP1A2 inhibitor, Thiabendazole, may increase the effects and toxicity of Guanabenz by decreasing Guanabenz metabolism and clearance. Monitor for changes in the therapeutic and adverse effects of Guanabenz if Thiabendazole is initiated, discontinued or dose changed. [drugbank_resource:DB00629_DB00730]" assertion.
- drugbank_resource:DB00629_DB00730 identifier "drugbank_resource:DB00629_DB00730" assertion.
- drugbank_resource:DB00629_DB00730 title "DDI between Guanabenz and Thiabendazole - The strong CYP1A2 inhibitor, Thiabendazole, may increase the effects and toxicity of Guanabenz by decreasing Guanabenz metabolism and clearance. Monitor for changes in the therapeutic and adverse effects of Guanabenz if Thiabendazole is initiated, discontinued or dose changed." assertion.
- drugbank:DB00730 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00629_DB00730 assertion.
- drugbank:DB00629 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00629_DB00730 assertion.